Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Inspira Technologies Oxy BHN ( (IINN) ).
Inspira Technologies reported its financial results for the first half of 2025, highlighting significant milestones such as securing $49.5 million in binding purchase orders and achieving clinical validation in leading hospitals. The company has transitioned to commercial execution, with its technology being adopted in premier U.S. hospitals and generating global interest. Inspira’s HYLA blood sensor achieved 97.35% accuracy, and the company is preparing for FDA submission. With strategic patent protection and plans to scale manufacturing, Inspira aims for a $70 million annual revenue run rate in 2026, reinforcing its position in advanced respiratory care.
The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.
Spark’s Take on IINN Stock
According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.
The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.
To see Spark’s full report on IINN stock, click here.
More about Inspira Technologies Oxy BHN
Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The company offers the FDA-cleared INSPIRA ART100 system for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S. Additionally, they are developing the INSPIRA ART500 and the HYLA blood sensor platform, positioning themselves as a significant player in the life-support and MedTech landscape.
Average Trading Volume: 1,148,698
Technical Sentiment Signal: Buy
Current Market Cap: $32.54M
For an in-depth examination of IINN stock, go to TipRanks’ Overview page.